Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Outlines Biosimilar First Interchangeability Policy … In A Memo
Nov 13 2023
•
By
Derrick Gingery
The memo on Humira biosimilars reveals some interchangeable exclusivity policies but there is more unpacking to do. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Biosimilars
More from Biosimilars & Generics